P/93/2010

Key facts

Invented name
Janumet and associated names
Active substance
  • sitagliptin phosphate monohydrate
  • metformin hydrochloride
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/93/2010
PIP number
P/93/2010
Pharmaceutical form(s)
  • Film-coated tablet
  • Modified-release tablet
Condition(s) / indication(s)
Treatment of type II diabetes mellitus
Route(s) of administration
Oral use
Contact for public enquiries
Merck Sharp & Dohme (Europe), Inc.
Belgium
E-mail: pip.information@merck.com
Tel. +31 412663179
Fax +31 412662571
Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

Related information

How useful was this page?

Add your rating